- Home
- SLN vs CZNC Comparison
SLN vs CZNC Comparison
Compare SLN & CZNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLN
- CZNC
- Stock Information
- Founded
- SLN 1994
- CZNC 1864
- Country
- SLN United Kingdom
- CZNC United States
- Employees
- SLN N/A
- CZNC N/A
- Industry
- SLN Biotechnology: Pharmaceutical Preparations
- CZNC Major Banks
- Sector
- SLN Health Care
- CZNC Finance
- Exchange
- SLN Nasdaq
- CZNC Nasdaq
- Market Cap
- SLN 345.3M
- CZNC 312.9M
- IPO Year
- SLN N/A
- CZNC N/A
- Fundamental
- Price
- SLN $6.24
- CZNC $19.24
- Analyst Decision
- SLN Buy
- CZNC Hold
- Analyst Count
- SLN 6
- CZNC 1
- Target Price
- SLN $39.67
- CZNC $22.00
- AVG Volume (30 Days)
- SLN 213.8K
- CZNC 45.9K
- Earning Date
- SLN 11-07-2025
- CZNC 10-23-2025
- Dividend Yield
- SLN N/A
- CZNC 5.82%
- EPS Growth
- SLN N/A
- CZNC 21.82
- EPS
- SLN N/A
- CZNC 1.75
- Revenue
- SLN $27,169,000.00
- CZNC $109,632,000.00
- Revenue This Year
- SLN N/A
- CZNC $5.72
- Revenue Next Year
- SLN N/A
- CZNC $7.18
- P/E Ratio
- SLN N/A
- CZNC $10.99
- Revenue Growth
- SLN 22.28
- CZNC 7.59
- 52 Week Low
- SLN $1.97
- CZNC $17.85
- 52 Week High
- SLN $18.24
- CZNC $22.68
- Technical
- Relative Strength Index (RSI)
- SLN 46.82
- CZNC 45.91
- Support Level
- SLN $7.06
- CZNC $18.97
- Resistance Level
- SLN $7.39
- CZNC $19.84
- Average True Range (ATR)
- SLN 0.58
- CZNC 0.35
- MACD
- SLN -0.12
- CZNC -0.01
- Stochastic Oscillator
- SLN 21.87
- CZNC 31.45
About SLN Silence Therapeutics Plc American Depository Share
Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid or siRNA. Using its mRNAi GOLD platform, the company has generated siRNA product candidates both for internal development pipeline as well as for out-licensed programs with third-party collaborators. Its wholly owned pipeline is focused on three therapeutic areas: cardiovascular disease, hematology, and rare diseases. The different product candidates in its pipeline are Divesiran (SLN124), a siRNA product candidate that has the potential to treat several hematological disorders; Zerlasiran (SLN360), being developed as a potential treatment to reduce cardiovascular issues; SLN-312; SLN-548; and multiple other programs.
About CZNC Citizens & Northern Corp
Citizens & Northern Corp is a community bank operating through its subsidiaries. It provides banking services, including deposit and loan products for personal and commercial customers. The bank also maintains a trust division that provides a wide range of financial services, such as 401(k) plans, retirement planning, estate planning, estate settlements and asset management.